How have the EMA’s latest updates affected your IDMP preparation efforts? Watch this fireside chat with Patrick Middag, Bristol Myers Squibb, and Alastair Nixon, GSK to hear how they are adapting to the new IDMP guidance and using it as an opportunity to derive even greater value from their RIM solution.

They also reviewed several steps that your organization can take in the coming months to prepare for compliance.

More Customer Stories

AstraZeneca, Bristol Myers Squibb and Takeda: Beyond IDMP Compliance
Maximizing Data
Eli Lilly Accelerates RIM Deployment with Agile Approach
Discover the Benefits
Building the Business Case for Unified RIM
Explore the Rollout

Interested in learning more about Veeva?